Skip to content

ACURA PHARMACEUTICALS, INC.: filings

Every ACURA PHARMACEUTICALS, INC. annual and quarterly report in the SEC record with the published financial measures it tagged, 43 filings, each linked to its SEC index.

Filing record ends 2023-06-30

The latest filing in this captured record is a 10-K filed 2023-06-30. No later filing is in the SEC companyfacts record captured on 2026-09-22. ACURA PHARMACEUTICALS, INC. may have stopped filing, merged, or changed its reporting entity; nothing on this page describes its current status. Values are as reported at the time.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-K2023-06-30fiscal FY 202136740001410578-23-001462
10-Q2021-11-15fiscal Q3 2021351080001104659-21-139198
10-Q2021-08-16fiscal Q2 2021341000001104659-21-106351
10-Q2021-05-17fiscal Q1 202134730001104659-21-068109
10-K2021-03-31fiscal FY 202033680001104659-21-044760
10-Q2020-11-16fiscal Q3 2020331050001104659-20-125816
10-Q2020-08-14fiscal Q2 2020331010001104659-20-095517
10-Q2020-06-29fiscal Q1 202033710001104659-20-078057
10-K2020-03-31fiscal FY 201934700001104659-20-040632
10-Q2020-02-28fiscal Q3 2019351110001104659-20-026512
10-Q2020-02-10fiscal Q2 2019341000001104659-20-013529
10-Q2019-10-01fiscal Q1 201935720001144204-19-046746
10-K2019-09-16fiscal FY 2018411230001144204-19-044723
10-Q2018-11-27fiscal Q3 2018381020001144204-18-061732
10-Q2018-08-14fiscal Q2 2018371000001144204-18-044691
10-Q2018-06-29fiscal Q1 201837760001144204-18-036698
10-K2018-06-07fiscal FY 2017441290001144204-18-033269
10-Q2017-11-13fiscal Q3 2017441200001144204-17-058390
10-Q2017-08-14fiscal Q2 2017391100001144204-17-043189
10-Q2017-05-12fiscal Q1 201738760001144204-17-026909
10-K2017-03-31fiscal FY 2016401200001144204-17-018146
10-Q2016-11-14fiscal Q3 2016411100001144204-16-134413
10-Q2016-08-08fiscal Q2 2016411100001144204-16-117260
10-Q2016-05-02fiscal Q1 201642840001144204-16-098297
10-K2016-02-29fiscal FY 2015391190001144204-16-085018
10-Q2015-11-04fiscal Q3 2015381060001144204-15-062776
10-Q2015-08-03fiscal Q2 2015371050001144204-15-045799
10-Q2015-05-04fiscal Q1 201535720001144204-15-027285
10-K2015-03-02fiscal FY 2014391480001144204-15-013292
10-Q2014-11-03fiscal Q3 201434960001144204-14-064695
10-Q2014-08-04fiscal Q2 2014371020001144204-14-046751
10-Q2014-05-05fiscal Q1 201436740001144204-14-027579
10-K2014-03-03fiscal FY 2013381450001144204-14-012919
10-Q2013-11-04fiscal Q3 201334950001144204-13-058571
10-Q2013-08-01fiscal Q2 201334970001144204-13-042470
10-Q2013-05-02fiscal Q1 201332660001144204-13-025986
10-K2013-03-04fiscal FY 2012371440001144204-13-012648
10-Q2012-11-06fiscal Q3 201228820001144204-12-059770
10-Q/A2012-08-09fiscal Q2 201228820001144204-12-043850
10-Q2012-05-01fiscal Q1 201223480001144204-12-025292
10-K2012-03-05fiscal FY 201129800001144204-12-012928
10-Q2011-10-31fiscal Q3 201128760001144204-11-060318
10-Q2011-07-28fiscal Q2 201126760001144204-11-042613

Inspect the source

Entity
ACURA PHARMACEUTICALS, INC. / CIK 0000786947
Captured
SEC response SHA-256
ddd4d46d7b653866393750aca5b4b8df0b1d01cc12bf538dec173ecb04c700be

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000786947.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))